Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

31st Psychiatric Pharmacotherapy Update • CME, CNE, APA, SW


Psychiatric Pharmacotherapy Update • CME, CNE, APA, SW Registration Page

October 17 & 18, 2019 • Austin, TX

CME, CNE, APA, SW Credit Registration


Welcome

The University of Texas College of Pharmacy welcomes you to the 31st Psychiatric Pharmacotherapy Update CE event, in Austin, Texas on October 17 & 18, 2019. The Psychiatric Pharmacotherapy Update traditionally provides 15 hours of CEUs on current trends in mental illness treatment for pharmacists, physicians, psychiatrists, psychologists, advance practice nurses, counselors, and social workers.

austin and hotel photos

Registration Information:

  1. Set up a new ID or log in to your existing account.  Use the "forgot password" feature to retrieve your log on information.
  2. Answer the registration questions.  Note, these questions help with the event planning.
  3. Register for the event, credit card or check payment options available.
  4. Groups:  Call the College of Pharmacy CE office for information on how to register multiple participants.
  5. Bookmark the registration page!  This is the same log on site that will be used during the event for viewing presentation slides and access to complete evaluations for CE credit.

Refund Policy:
An 80% refund will be issued if notification of cancellation is made to College of Pharmacy Continuing Education by October 1, 2019. If payment of registration was made by check, please allow up to 60 days for refund. Refunds will not be made for cancellations received after October 1, 2019; however, substitute registrants will be accepted.

Pre-Conference Workshops (Opiontal yet included in Conference Registration):
New this year, two pre-conference workshops taking place on Wednesday, Oct 16.  The programs include:
  • Opioid Use Disorder Update - Wednesday Afternoon - 3.00 CE
  • Tardive Dyskinesia Update and Training Wednesday Evening - 2.00 CE
Seperate Registration Required for Pre-Conference Workshops.  See the website for more information. (link opens in new window)

Pharmacy CPE Registration:
This site is for those seeking CME, CNE, APA, or SW credit.  For Pharmacy CPE registration, please return to the conference home page and choose the Pharmacist Registration option.


 
 
 

Date: Oct 16, 2019 02:00 PM - Oct 18, 2019 05:00 PM

Location: Double Tree North Hotel Austin, 6505 North IH-35, Austin, TX, 78752

Fee

$525.00

CE Hours

15.00

CE Units

1.500

Registration closes on Oct 20, 2019 10:00 AM

Activity Type

  • Knowledge

Target Audience(s)

  • Physicians
  • Psychiatrists
  • Physician Assistant
  • Nurses
  • Social Workers
  • Psychologists
  • Counselors

 

 

 

   

Please join us for a welcome reception.

No registration for Wednesday programs required. 
Date: 10/16/19
Time: 05:30 PM - 07:00 PM
   

 

   

Check-in at front desk.  Please be sure to wear nametag through the event, and during meals and breaks.
 
Date: 10/17/19
Time: 07:00 AM - 05:30 PM
   

   

Date: 10/17/19
Time: 07:15 AM - 07:45 AM
   

   

Date: 10/17/19
Time: 07:45 AM - 08:00 AM
   

   

Navigation of Healthcare System: A Patient and Peer Recovery Specialist Perspective
 
Learning Objectives:
  • Describe the psychiatric healthcare system experience from the patient and peer recovery specialist perspective.
  • Discuss case studies from the view of the patient in regards to healthcare provider interactions.
  • Discuss ethical issues related to patient and healthcare provider communication.
 
Moderator:
 
Lisa M. Mican, PharmD, BCPP
Director of Pharmacy
Clinical Coordinator
Austin State Hospital
 
Panelists:

Amy Pierce
CPS-Peer Specialist Integration Field Laison
Via Hope

Joe Powell
President and CEO
Association of Persons Affected by Addiction


 

Activity Number

0067-0000-19-117-L01-P
Date: 10/17/19
Time: 08:00 AM - 09:00 AM

CE Hours

1.00
   

   

Tardive Dyskinesia Update
 
Learning Objectives:
  • Evaluate for the presence and severity of tardive dyskinesia (TD) based on commonly used rating scales.
  • Assess the safety and efficacy of pharmacologic treatments for TD.
  • Develop a treatment plan based on the safety and efficacy of the pharmacologic options to treat TD.
 
Steven Stoner, Pharm.D., BCPP
Chair and Clinical Professor
Division of Pharmacy Practice and Administration
University of Missouri Kansas City School of Pharmacy

 

Activity Number

0067-0000-19-118-L01-P
Date: 10/17/19
Time: 09:00 AM - 10:00 AM

CE Hours

1.00
   

   

Refershments in the classroom lobby
Date: 10/17/19
Time: 10:00 AM - 10:15 AM
   

   

Behavioral Threat Assessment and Psychopharmacological Approaches to Managing the Potential Violence
 
Learning Objectives
  • Discuss evidence-based factors correlative with risk for violence.
  • Describe best practices and the use of structured professional judgment to assess relative risk for affective and predatory violence.
  • Discuss about the Pathway to Violence and intervention strategies to mitigate escalation from grievance to attack.
  • Discuss the ethical pitfalls of behavioral profiling / biases yielding false positives and false negatives in assessing future violence risk.
  • Evaluate the literature for evidence of effective pharmacological treatments of chronic violence and aggression
 
Matt Talbot, LCSW, CCFC, CFMHE, CTM
ATAP Certified Threat Manager
Triple Threat Assessment and Prevention Consulting, LLC
 
Kasey Leggette Pena, Pharm.D.
Clinical Psychiatric Pharmacist
Austin State Hospital

 

Activity Number

0067-0000-19-119-L01-P
Date: 10/17/19
Time: 10:15 AM - 11:45 AM

CE Hours

1.50
   

   

Pick up lunch in the lobby area, and return to the ballroom for the next session.
Date: 10/17/19
Time: 11:45 AM - 12:15 PM
   

   

Psychiatric Disorder Later in Life
 
Learning Objectives
  • Discuss indication, dosing protocol and common adverse events for FDA-approved rapid-acting antidepressants (esketamine)
  • Discuss the evidence base for off-label ketamine use in depression
 
Rajesh R. Tampi, M.D., M.S., D.F.A.P.A.
Professor of Psychiatry
Case Western Reserve University School of Medicine
Associate Clinical Professor of Psychiatry, Yale School of Medicine
President Elect, American Association for Geriatric Psychiatry

 

Activity Number

0067-0000-19-120-L04-P
Date: 10/17/19
Time: 12:15 PM - 01:15 PM

CE Hours

1.00
   

   

Ketamine for the use of Psychiatric Disorders
 
Learning Objectives
  • Discuss indication, dosing protocol and common adverse events for FDA-approved rapid-acting antidepressants (esketamine)
  • Discuss the evidence base for off-label ketamine use in depression
 
Samuel Wilkinson, M.D.
Assistant Professor & Assistant Director
Yale Depression Research Program
Yale School of Medicine

 

Activity Number

0067-0000-19-121-L01-P
Date: 10/17/19
Time: 01:15 PM - 02:15 PM

CE Hours

1.00
   

   

Refershments in the classroom lobby
Date: 10/17/19
Time: 02:15 PM - 02:30 PM
   

   

Cannabidiol Use for Psychiatric and Neurological Conditions
 
Learning Objectives
  • Describe the role that clinicians are able play in patient use of medical cannabis
  • Discuss the key pharmacological differences between Δ9-tetrahydrocannabinol and cannabidiol
  • Discuss the risks and benefits of medical cannabis and how to educate a patient.
 
Jeffrey D. Gold, Pharm.D., BCPP
Mental Health Clinical Pharmacy Specialist
Denver VA Medical Center
PGY2 Psychiatric Pharmacy Residency Director

 

Activity Number

0067-0000-19-122-L01-P
Date: 10/17/19
Time: 02:30 PM - 03:30 PM

CE Hours

1.00
   

   

Review of Clinically Significant Drug Interactions
 
Learning Objective
  • Discuss evidence-based review of clinically significant psychiatric drug interaction of recently approved psychotropic agents
 
Stephen R. Saklad, Pharm.D., BCPP
Clinical Associate Professor
The University of Texas at Austin College of Pharmacy

 

Activity Number

0067-0000-19-123-L01-P
Date: 10/17/19
Time: 03:30 PM - 04:30 PM

CE Hours

1.00
   

   

Join us for a networking reception following the first day's programming.
Date: 10/17/19
Time: 04:30 PM - 06:00 PM
   

 

   

Registration and Information available at the front desk.
Date: 10/18/19
Time: 07:30 AM - 04:30 PM
   

   

Date: 10/18/19
Time: 07:30 AM - 08:00 AM
   

   

Date: 10/18/19
Time: 07:45 AM - 08:00 AM
   

   

Psychopharmacology Myths or Facts: Focus on Mood Disorders
 
Learning Objectives
  • Examine common misperceptions in psychopharmacology related to mood disorders
  • Evaluate the evidence for psychopharmacologic treatments approaches stemming from anecdotal evidence
  • Apply evidence-supported interventions using a case example
 
Tawny Smith, Pharm.D., BCPP.
Associate Professor of Psychiatry
The University of Texas at Austin Dell Medical School
 
Samantha Vogel, Pharm.D., BCPP.
Clinical Assistant Professor for Pharmacy Practice
The University of Texas at Austin College of Pharmacy

 

Activity Number

0067-0000-19-124-L01-P
Date: 10/18/19
Time: 08:00 AM - 09:00 AM

CE Hours

1.00
   

   

Neurobiology and Pharmacological Treatment of Opioid Use Disorder
 
Learning Objecties
  • Discuss the neurobiology of opioid use disorder (OUD)
  • Recall the DSM-5 diagnostic criteria for OUD
  • Compare the mechanisms of FDA-approved medications for OUD
  • Contrast patient outcomes associated with medications for OUD
  • Discuss ethical issues faced by healthcare professionals in working with OUD diagnosis, naloxone standing orders, and treatments for OUD.
 

Lucas G. Hill, Pharm.D
Clinical Assistant Professor
The University of Texas at Austin College of Pharmacy


 

Activity Number

0067-0000-19-125-L01-P
Date: 10/18/19
Time: 09:00 AM - 10:00 AM

CE Hours

1.00
   

   

Refershments in the classroom lobby
Date: 10/18/19
Time: 10:00 AM - 10:15 AM
   

   

Forensic Psychiatry: The Journey to Competency Restoration
 
Learning Objectives
  • Review statutes governing competency to stand trial
  • Discuss the process by which individuals are court ordered to a hospital for treatment and return to court
  • Describe the role of medication treatment in the competency to stand trial evaluation and competency restoration
  • Describe how psychiatric and psychological factors impact competency                                                            
 
Andrea Wright, MD
Psychiatrist
Austin State Hospital
 

 

Activity Number

0067-0000-19-126-L01-P
Date: 10/18/19
Time: 10:15 AM - 11:15 AM

CE Hours

1.00
   

   

Cognitive Adaptation Training (CAT)
 
Learning Objecties
  • Discuss environmental supports used in cognitive adaption training to improve adherence to oral antipsychotic medications in mental health patients
  • Discuss use of cognitive adaptation training for use in treatment with schizophrenia patients to improve adherence to medication and behavioral management
 
Natalie Maples, M.A., DrPh(c)
Faculty Specialist, Department of Psychiatry
Division of Community Recovery, Research and Training
The University of Texas Health San Antonio
 

 

Activity Number

0067-0000-19-126-L01-P
Date: 10/18/19
Time: 11:15 AM - 12:15 PM

CE Hours

1.00
   

   

Pick up box lunch in the prefunction area, and return to the ballroom for the next session.  This set up was developed to ensure an earlier close and departure for the day.
Date: 10/18/19
Time: 12:15 PM - 12:30 PM
   

   

PTSD: From Combat to Community
 
Learning Objectives
  • Discuss medication, therapy and medication assisted/combined therapy.
  • Discuss differentiation of literature regarding treatment of combat and non-combat related PTSD.
  • Review evidence-based best practices and contradictions in practice between combat and non-combat PTSD
 
Troy A. Moore, Pharm.D., M.S. Pharm., BCPP
PGY-1 Pharmacy Residency Program Director
Clinical Pharmacy Specialist in Mental Health
VA Eastern Colorado Health Care System
 
Katie Dahm, Ph.D.
Clinical Psychologist / PTSD Clinical Team
VA Eastern Colorado Health Care System
Instructor, University of Colorado School of Medicine, Psychiatry

 

Speaker(s)/Author(s)

Troy Moore PharmD, MS Pharm, BCPP picture

Troy Moore PharmD, MS Pharm, BCPP
Clinical Pharmacy Specialist – Psychiatry Director, ASHP-Accredited PGY-2 Psychiatric Pharmacy Residency Program Co-Director, Interprofessional Advanced Fellowship in Addiction Treatment, South Texas Veterans Health Care System

Activity Number

0067-0000-19-127-L01-P
Date: 10/18/19
Time: 12:45 AM - 02:15 PM

CE Hours

1.50
   

   

Refershments in the classroom lobby
Date: 10/18/19
Time: 02:15 PM - 02:30 PM
   

   

Management of Delirium: Pharmacologic and Non-Pharmacologic Treatments that Work
 
Learning Objectives
  • Discuss pharmacologic and nonpharmacologic treatment strategies for delirium.
  • Identify signs and symptoms of delirium
 
Smitha Murthy, M.D.
Assistant Professor of Psychiatry
The University of Texas at Austin Dell Medical School

 

Activity Number

0067-0000-19-128-L01-P
Date: 10/18/19
Time: 02:30 PM - 03:30 PM

CE Hours

1.00
   

   

Psychotropic New Drug Update 
 
Learning Objectives
  • Describe the pharmacology, adverse effects, drug interactions, therapeutic uses, and dosing of selected psychiatric drugs recently marketed as well as drugs approaching the market.
  • Review pharmacology, adverse effects, drug interactions, therapeutic uses, and dosing of selected psychiatric drugs that have been released in the past five years
 
Stephen R. Saklad, Pharm.D., BCPP
Clinical Associate Professor
The University of Texas at Austin College of Pharmacy

 

Activity Number

0067-0000-19-129-L01-P
Date: 10/18/19
Time: 03:30 PM - 04:30 PM

CE Hours

1.00
   

   

Date: 10/18/19
Time: 12:00 PM - 12:00 PM